284 related articles for article (PubMed ID: 3518963)
41. Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.
Kamimura T; Matsumoto Y; Okada N; Mine Y; Nishida M; Goto S; Kuwahara S
Antimicrob Agents Chemother; 1979 Nov; 16(5):540-8. PubMed ID: 525994
[TBL] [Abstract][Full Text] [Related]
42. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Barry AL; Brown SD; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
[TBL] [Abstract][Full Text] [Related]
43. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
Bint AJ; Yeoman P; Kilburn P; Anderson R; Stansfield E
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():47-51. PubMed ID: 19802968
[TBL] [Abstract][Full Text] [Related]
44. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
Washington JA II
J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
[TBL] [Abstract][Full Text] [Related]
45. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
Shah PM; Zwischenbrugger H; Stille W
MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
[TBL] [Abstract][Full Text] [Related]
46. In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
Leigh DA; Marriner J
J Antimicrob Chemother; 1983 Jan; 11 Suppl():103-5. PubMed ID: 6573310
[TBL] [Abstract][Full Text] [Related]
47. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
Dabernat HJ; Delmas C
Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
[TBL] [Abstract][Full Text] [Related]
48. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.
Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S
Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Appelbaum PC; Tamim J; Pankuch GA; Aber RC
Chemotherapy; 1983; 29(5):337-44. PubMed ID: 6311492
[TBL] [Abstract][Full Text] [Related]
50. Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Clin Microbiol; 1986 Dec; 24(6):1055-9. PubMed ID: 3097064
[TBL] [Abstract][Full Text] [Related]
51. [Timed bacteriostatic and bactericidal activities of cefmetazole against selected gram-negative bacteria].
Masuda G; Young C; Negishi M; Watanabe T; Yamazaki E; Motegi K
Jpn J Antibiot; 1982 Sep; 35(9):2288-92. PubMed ID: 6754988
[TBL] [Abstract][Full Text] [Related]
52. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
Jones RN; Barry AL; Aldridge KE; Gerlach EH
Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
[TBL] [Abstract][Full Text] [Related]
53. Ceftazidime: comparative in-vitro study.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():67-71. PubMed ID: 19802971
[TBL] [Abstract][Full Text] [Related]
54. Newer cephalosporins and cephamycins--a review.
Norrby R
Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
[TBL] [Abstract][Full Text] [Related]
55. The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Neu HC
Annu Rev Pharmacol Toxicol; 1982; 22():599-642. PubMed ID: 6282190
[No Abstract] [Full Text] [Related]
56. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Concia E; Marone P; Verani D; Marino P
Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
[TBL] [Abstract][Full Text] [Related]
57. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Norris SM; Guenthner SH; Wenzel RP
J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
[TBL] [Abstract][Full Text] [Related]
58. Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.
Counts GW; Turck M
Antimicrob Agents Chemother; 1979 Jul; 16(1):64-8. PubMed ID: 112919
[TBL] [Abstract][Full Text] [Related]
59. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Eickhoff TC; Ehret J
Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
[TBL] [Abstract][Full Text] [Related]
60. The influence of cefepime on opsonophagocytosis of bacteria.
Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
